RPL7P9

Across TCGA pan-cancer cohorts, RPL7P9 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated RPL7P9 data layer compared with 2 for mass-spec protein.

The strongest signal is observed in uveal melanoma (UVM), where higher RPL7P9 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL7P9 expression acts as an unfavorable survival marker, although some lineages such as THCA and LGG show a favorable association.

UVM, ACC, and LUAD are the cancer types where RPL7P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	III,IV	0.410	0.955	<.001	94	view →
ACC	DFS	Median	All	0.227	0.643	<.001	72	view →
LUAD	DFS	Tertile	II,III,IV	0.598	0.772	.002	55	view →
KIRP	DFS	Quartile	All	0.823	0.963	.004	49	view →
THCA	DFS	Tertile	All	0.980	0.901	.002	44	view →
LGG	DFS	Median	All	0.803	0.661	<.001	40	view →
ESCA	OS	Median	II,III,IV	0.389	0.581	.001	35	view →
LIHC	OS	Quartile	All	0.564	0.750	.003	34	view →
UCEC	DFS	Median	All	0.565	0.710	.004	34	view →
MESO	DFS	Median	All	0.667	0.233	.001	27	view →
CHOL	OS	Median	II,III,IV	0.875	0.271	.003	24	view →
OV	OS	Tertile	II,III,IV	0.629	0.733	.019	20	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

RPL7P9–UVM (DFS)

Open the UVM breakdown →